Areas of Application
The medicinal product for treatment
and prevention of skin fungal infections
Specifi cation
The TD has an effective fungicide
action against Candida albicans,
Candida tropicalis, Trychophyton rubrum,
Microsporum canis and a signifi cant bactericide
action against gram-positive and gram-negative
microorganisms, is low-toxic, doesn’t cause
any carcinogen, allergic, mutagen, and teratogen
effects; doesn’t accumulate in the organism.
The product has been registered
by the Ministry of Health of Ukraine
Advantages
TD outperforms the known reference drugs
by effi cacy, tolerability, and absence
of negative effects on the human organism.
The average treatment time decreases by 29%,
the effi cacy and the tolerability improve
from 2.15 to 1.32 and from 1.87 to 1.09,
respectively (1 is the highest score).
The TD manufacture is periodic, non-waste,
and ecologically safe
Stage of Development.
Suggestion for Commercialization
IRL8, TRL9
The antimycotic agent and manufacturing
technology are proposed
IPR Protection
IPR1, IPR3
For more information or to license this innovation:
- Log In
to view the innovation's details
- Sign Up
with discount code "ECOS"
